Parabilis Medicines
Developing HeliconTM peptides drugs
- B2B
About Parabilis Medicines
FogPharma is developing HeliconTM peptides, a new drug modality that combines monoclonal antibodies with small molecules for broad, efficient drug targeting
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- cambridge, massachusetts, United States
- Founded
- 2016
- Revenue
- $21.5M – $170MTamtam estimate
- Website
- parabilismed.com
Parabilis Medicines at a glance
Parabilis Medicines is a B2B company in the Biotechnology Research industry, headquartered in cambridge, massachusetts, United States.
Parabilis Medicines was founded in 2016.
Parabilis Medicines has 51–250 employees.
Parabilis Medicines's revenue is $21.5M – $170M (Tamtam estimate).
Frequently asked questions about Parabilis Medicines
What is Parabilis Medicines's revenue?
Tamtam estimates Parabilis Medicines's annual revenue at $21.5M – $170M.
How many employees does Parabilis Medicines have?
Parabilis Medicines has 51–250 employees.
Where is Parabilis Medicines headquartered?
Parabilis Medicines is headquartered in cambridge, massachusetts, United States.
Selling to companies like Parabilis Medicines?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies